Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'

ktsimage/iStock via Getty Images Omega Therapeutics, Inc. (NASDAQ:OMGA) was founded in 2017 and is one of the companies created by Flagship Pioneering, a biotech incubator. OMGA is at the forefront of a new approach in biomedicine with its proprietary platform, which allows the development of programmable epigenomic mRNA medicines to control gene manifestation before the transcription phase when mRNA is synthesized, preserving DNA sequencing. Leveraging this platform, the company can engineer targeted t ...